Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Enzymes Market Set To Climb From $17.28 Billion In 2026 To $28.7 Billion By 2030
The enzymes market has experienced substantial expansion in recent years. It will grow from $15.2 billion in 2025 to $17.29 billion in 2026 at a compound annual growth rate (CAGR) of 13.7%. Historically, this growth is linked to factors such as an increasing need for therapeutic enzymes, advancements in microbial fermentation technology, enhanced biotechnology research, the implementation of enzyme-based diagnostic tools, and the enlargement of pharmaceutical production.
The enzymes market is projected for swift expansion in the coming years, reaching $28.7 billion in 2030 with a compound annual growth rate (CAGR) of 13.5%. This projected growth during the forecast period stems from factors such as the rise of personalized medicine, progress in protein engineering, increased demand for industrial enzymes in the food and beverage sectors, a greater emphasis on sustainable enzyme manufacturing, and the expansion of developing markets in the Asia-Pacific region. Key trends anticipated for this period encompass enzyme engineering and protein design, the broadening of industrial enzyme applications, personalized enzyme therapy, advancements in microbial enzymes, and the development of eco-friendly and sustainable enzyme production methods.
Get A Free Sample Report With In-Depth Market Insights:
Enzymes Market Growth Momentum: What Factors Are Shaping Demand?
The escalating incidence of cancer, which necessitates drug-metabolizing enzymes (DMEs) for effective chemotherapy, is projected to propel the expansion of the enzyme market in the coming years. The activation of enzymes within the human body plays a vital role in eliminating cancer cells and breaking down tumors. Therefore, the expression and proper functioning of drug-metabolizing enzymes (DMEs) in the tumor tissues and metabolic organs of cancer patients are indispensable, providing crucial support for patients who exhibit low reaction to anticancer drugs and poor response to chemotherapy. For instance, in September 2025, according to the American Cancer Society, a US-based professional organization, an estimated 313,780 new cases of prostate cancer are anticipated in the United States in 2025. The risk of developing prostate cancer also increases sharply with age, escalating from 0.2% in men under 50 to 6.5% in those aged 70–79. Consequently, the rising prevalence of cancer conditions amenable to treatment with therapeutic enzymes is expected to fuel the enzyme market growth.
Enzymes Market Segmentation: How Does The Market Break Down By Category?
The enzymes market covered in this report is segmented –
1) By Product Type: Asparaginase, Lipase, Protease, Nattokinase, Chitinase, Serratiopeptidase, Collagenase, Ligase, Other Products
2) By Application: Leukemia, Stomach Disorders, Antitumor, Skin Ulcers, Gaucher Disease, Fabry Disease, Other Applications
3) By End User: Drug Manufacturers, Hospitals, Private Clinics, Research Laboratories
Subsegments:
1) By Asparaginase: L-asparaginase, Erwinia Asparaginase, Pegylated Asparaginase
2) By Lipase: Gastric Lipase, Pancreatic Lipase, Fungal Lipase, Bacterial Lipase
3) By Protease: Serine Proteases, Cysteine Proteases, Aspartic Proteases, Metalloproteases
4) By Nattokinase: Nattokinase Powder, Nattokinase Capsules
5) By Chitinase: Plant Chitinase, Microbial Chitinase
6) By Serratiopeptidase: Serratiopeptidase Tablets, Serratiopeptidase Capsules
7) By Collagenase: Type I Collagenase, Type II Collagenase, Type III Collagenase
8) By Ligase: DNA Ligase, RNA Ligase
9) By Other Products: Amylase, Cellulase, Beta-Glucanase
Enzymes Market Trends Redefining Industry Growth
Key players in the enzyme market are actively developing innovative products, such as Lamzede, to enhance patient care. Lamzede (velmanase alfa) is a medication specifically designed for the treatment of alpha-mannosidosis, a rare genetic condition resulting from deficient activity of the lysosomal alpha-galactosidase-A enzyme. For instance, in May 2023, Chiesi Global Rare Diseases, a US-based pharmaceutical manufacturing company, secured FDA approval for Lamzede (velmanase alfa) for managing non-neurological symptoms in patients with mild-to-moderate alpha-mannosidosis. This drug, Lamzede, is a recombinant form of human alpha-mannosidase, engineered in mammalian Chinese hamster ovary (CHO) cells through recombinant DNA technology. It holds the distinction of being the first enzyme replacement therapy approved in the U.S. for addressing the non-central nervous system manifestations of alpha-mannosidosis.
Enzymes Market Competitive Overview And Top Companies
Major companies operating in the enzymes market are Novozymes A/S, DuPont Industrial Biosciences, BASF SE, Koninklijke DSM N.V., Chr. Hansen Holding A/S, Roche Holding AG, Advanced Enzyme Technologies Ltd., AB Enzymes GmbH, Codexis Inc., Dyadic International Inc., Amano Enzyme Inc., Adisseo France SAS, Biocatalysts Ltd., Amano Enzyme Inc., Enzyme Development Corporation, Creative Enzymes, Hayashibara Co. Ltd., Thermo Fisher Scientific Inc., Associated British Foods Plc, Lonza Group AG, Novus International Inc., Epygen Biotech, DSM Nutritional Products AG, Soufflet Biotechnologies SAS, Beijing Leili Marine Bioindustry Inc., Jiangsu Boli Bioproducts Co. Ltd.
View The Full Enzymes Market Report:
Enzymes Market Leading Geography: Which Region Contributes The Most Revenue?
North America was the largest region in the enzymes market in 2025. The regions covered in the enzymes market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
